Profil
Joel F.
Martin was the founder of Sofinnova Investments, Inc. (1974) as President & Chief Executive Officer.
Dr. Martin was the founder of Dauntless Pharmaceuticals, Inc. (2015) as President, Chief Executive Officer & Director.
Dr. Martin is also the founder of Argonaut Technologies, Inc., Quantum Dot Corp., Intrepida Bio, Inc. Dr. Martin is currently President, Chief Executive Officer & Director at Dauntless 1, Inc. and President, Chief Executive Officer & Director at Dauntless 2, Inc. Former positions include President, Chief Executive Officer & Director at Cebix, Inc., President & Chief Executive Officer at Altair Therapeutics, Inc., Director at Hypnion, Inc., Principal at Institutional Venture Partners, and Member at Forward Ventures Services LLC (2001-2008).
Education includes a doctorate from the University of California San Diego and undergraduate and MBA degrees from the University of Michigan.
Postes actifs de Joel F. Martin
| Sociétés | Poste | Début |
|---|---|---|
Dauntless 2, Inc.
Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Directeur Général | - |
Dauntless 1, Inc.
Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Général | - |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines that modulates innate immune system to fight cancer | Fondateur | - |
Anciens postes connus de Joel F. Martin
| Sociétés | Poste | Fin |
|---|---|---|
Altair Therapeutics, Inc.
Altair Therapeutics, Inc. Medical DistributorsDistribution Services Discovers, develops and commercializes antisense drugs | Directeur Général | 09/03/2011 |
Forward Ventures Services LLC
Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements. | Membre du Comité d'Investissement | 31/12/2008 |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Fondateur | - |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Directeur Général | - |
Quantum Dot Corp.
Quantum Dot Corp. BiotechnologyHealth Technology Develop biomolecular detection novel solutions intended for clinical applications | Directeur Général | - |
Formation de Joel F. Martin
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Argonaut Technologies, Inc.
Argonaut Technologies, Inc. Miscellaneous Commercial ServicesCommercial Services Develops, manufactures, and markets products that enable chemists to use high speed parallel synthesis in the development of new drugs | Commercial Services |
Hypnion, Inc.
Hypnion, Inc. Miscellaneous Commercial ServicesCommercial Services Discovers and develops neuroscience drugs | Commercial Services |
Quantum Dot Corp.
Quantum Dot Corp. BiotechnologyHealth Technology Develop biomolecular detection novel solutions intended for clinical applications | Health Technology |
Cebix, Inc.
Cebix, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for complications of diabetes | Health Technology |
Institutional Venture Partners
Institutional Venture Partners Investment ManagersFinance Institutional Venture Partners invests in companies located in North America and Europe. The firm focuses on a broad range of sectors. It provides financing for growth stage capital requirements with the investment size of USD 15 - 75 millions. It also participates in follow on investments. | Finance |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Michigan
University of Michigan Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Forward Ventures Services LLC
Forward Ventures Services LLC Investment ManagersFinance Forward Ventures invests in companies located in the United States. The firm targets operating in the fields on life sciences and bio pharmaceuticals sectors. It provides financing for early stage capital requirements. | Finance |
Altair Therapeutics, Inc.
Altair Therapeutics, Inc. Medical DistributorsDistribution Services Discovers, develops and commercializes antisense drugs | Distribution Services |
Dauntless 1, Inc.
Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Retail Trade |
Dauntless 2, Inc.
Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Health Technology |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines that modulates innate immune system to fight cancer | Health Technology |
















